Intrinsic value of BioAtla, Inc. (BCAB)
Live fair value data for BioAtla, Inc. (BCAB) is currently unavailable. Please check again shortly.
Current Price: $334.00
Valuation: Undervalued
Confidence: 8.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is BioAtla, Inc. (BCAB) undervalued or overvalued?
Based on the current model output, BioAtla, Inc. appears to be undervalued with a upside of 32.00%.
Fair value vs market price — BioAtla, Inc. (BCAB)
Unlock premium access to view the live fair value comparison against current market price for BCAB.
Frequently Asked Questions - BCAB
How is BCAB intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for BCAB.
Is BCAB undervalued or overvalued right now?
BCAB is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for BCAB: open their intrinsic value pages.